Welcome to our dedicated page for BESSWS news (Ticker: BESSWS), a resource for investors and traders seeking the latest updates and insights on BESSWS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BESSWS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BESSWS's position in the market.
Bimergen Energy Corporation (NYSE American: BESS, BESSWS) priced an underwritten public offering at $4.00 per share (or pre-funded warrant) with one accompanying warrant, raising gross proceeds of $13,600,000 before fees.
Each warrant is exercisable for one share at $5.00, immediately exercisable for five years. The underwriters have a 45-day option for up to an additional 200,000 shares and 200,000 warrants. Trading is expected to begin on February 20, 2026, with closing targeted for February 23, 2026.